Tanios Bekaii-Saab, MD
Dr. Bekaii-Saab completed his undergraduate studies at McGill University and earned his MD at the American University of Beirut. His residency in internal medicine was at the Indiana University Medical Center, followed by fellowships in hematology/oncology and in clinical pharmacology at Tufts University-New England Medical Center.
Dr. Bekaii-Saab is Co-Leader of the Enterprise wide Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center and Professor at the Mayo Clinic College of Medicine and Science. He is actively involved in ASCO, AACR, and the American Society for Clinical Pharmacology and Therapeutics. Dr. Bekaii-Saab is co-leader for the hepato-biliary cancer committee for the Alliance cooperative group and the Alliance representative for the NCI hepato-biliary national cancer task force. He is also the SWOG representative for the NCI pancreatic cancer task force and senior executive leader for solid tumor research and GI cancer committee co-lead for the Mayo clinic- sponsored ACCRU network. An active peer reviewer for more than 50 prestigious journals, Dr. Bekaii-Saab has authored more than 350 peer-reviewed publications, abstracts in prominent journals, and book chapters.
Dr. Bekaii-Saab’s research interests include experimental therapeutics/translational research, molecular targeted and immune therapies. He is the principal investigator on numerous clinical trials supported by government, industry and NCCN. He has been awarded the prestigious NCI clinical investigator team leadership award and the ASCO leadership program development award.
Colorectal Cancer Editorial Board
Bassel F. El-Rayes, M.D.
Bassel F. El-Rayes, M.D. is the Director of the GI Oncology Clinical and Translational Research Program, Associate Cancer Research Director for Clinical Research at Winship Cancer Institute of Emory University and Associate Professor of Hematology and Oncology at Emory University School of Medicine. Dr. El-Rayes earned his bachelor’s degree in biology and doctoral degree from the American University of Beirut. He then completed his residency in internal medicine and fellowship in hematology and medical oncology at Wayne State University, Detroit. He is certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology and is an active member of the American Society of Clinical Oncology. He was on faculty at Wayne State University Karmanos Cancer Institute from 2003-2009. Dr El-Rayes clinical interests include gastrointestinal malignancies. Dr El-Rayes is a Georgia Cancer Coalition Distinguished Clinical Scholar. He has published over 75 peer reviewed articles in elite journals including Journal of Clinical Oncology and Cancer Research.
Antonia R. Sepulveda, MD, PhD, FACP
Dr. Antonia Sepulveda is Vice-Chair for Translational Research and Director of the Division of Gastrointestinal Pathology in the Department of Pathology & Cell Biology at Columbia University. Dr. Sepulveda is an experienced gastrointestinal and molecular pathologist with expertise combining conventional morphology and novel molecular applications for tissue diagnosis. Her clinical expertise is focused in Gastrointestinal and Pancreaticobiliary Pathology and her Molecular Pathology expertise is centered in solid tumor genomic and epigenetic molecular testing. She has served as the Chair of the Solid Tumor Subdivision of the Association for Molecular Pathology. Dr. Sepulveda’s research laboratory and the pathology translational research program at Columbia University are integrating conventional diagnostics with novel molecular testing applications of molecular biomarkers, with emphasis in genomic and epigenetic approaches for evaluation of cancer risk, diagnosis, prognosis and targeted therapies in digestive organ cancers and precursor lesions, including gastric, esophageal, colorectal and pancreaticobiliary tumors. Dr. Sepulveda has contributed numerous original research publications, reviews and chapters and is the Editor of a recently released book titled “Molecular Pathology of Neoplastic Gastrointestinal Diseases”.
Christina S. Wu, M.D.
Christina S. Wu, M.D., is an Assistant Professor of Internal Medicine in the Division of Medical Oncology at The Ohio State University-James Cancer Hospital and Solove Research Institute, Columbus, Ohio. Dr. Wu’s clinical interests include gastrointestinal malignancies and her research is focused on colorectal cancer and high risk colon cancer. She completed her medical school at the University of Dublin, Trinity College, Ireland and a post-doctoral research fellowship at Boston University School of Medicine in Boston, Massachusetts followed by her Internal Medicine Residency at the University of Massachusetts in Worcester, Massachusetts. Dr. Wu completed her training with a Hematology/Oncology Fellowship at Lombardi Comprehensive Cancer Center at Georgetown University Hospital in Washington D.C.